Experienced in Scleroderma

Christof Specker

Kliniken Essen Mitte
Essen, NW, DE 
Experienced in Scleroderma
Kliniken Essen Mitte
Essen, NW, DE 
OverviewLocationsClinical Research

Overview

Christof Specker practices in Essen, Germany. Mr. Specker is rated as an Experienced expert by MediFind in the treatment of Scleroderma. His top areas of expertise are Antisynthetase Syndrome, Rheumatoid Arthritis (RA), Gastrointestinal Perforation, and Arthritis.

His clinical research consists of co-authoring 111 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Scleroderma.

Gender
Male

Locations

Kliniken Essen Mitte
Essen, NW, Germany
Other Locations
Berlin, BE, Germany
Duesseldorf, NW, Germany
Wuerzburg, BY, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Clinical Efficacy of Two Different Doses of F8IL10 (Dekavil) Administered Subcutaneously to Patients With Active Rheumatoid Arthritis Receiving Methotrexate.
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Clinical Efficacy of Two Different Doses of F8IL10 (Dekavil) Administered Subcutaneously to Patients With Active Rheumatoid Arthritis Receiving Methotrexate.
Enrollment Status: Terminated
Publish Date: June 12, 2023
Intervention Type: Drug
Study Drugs: F8IL10, Methotrexate
Study Phase: Phase 2
Study Protocol for a Multi-Centre, Placebo-Controlled Phase II Study of Canakinumab for the Treatment of Adult-onset Still's Disease (AOSD) Including an Open-label Long Term Extension
Study Protocol for a Multi-Centre, Placebo-Controlled Phase II Study of Canakinumab for the Treatment of Adult-onset Still's Disease (AOSD) Including an Open-label Long Term Extension
Enrollment Status: Terminated
Publish Date: August 07, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

111 Total Publications

Acute inpatient rheumatology in Germany : Indispensable part of rheumatology care and specialist training
Acute inpatient rheumatology in Germany : Indispensable part of rheumatology care and specialist training
Journal: Zeitschrift fur Rheumatologie
Published: July 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Specker's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile